Exousia Bio LMMY
OTC LMMY
$0.02 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Exousia Bio (LMMY) EBITDA (2022 - 2026)

Updated

Exousia Bio's EBITDA was -$237,005 in fiscal Q3 2026 (quarter ended Feb 28, 2026), compared with $6,981 a year earlier.

Analysis

Exousia Bio (LMMY) EBITDA (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Exousia Bio's EBITDA was -$244,157 through Feb 28, 2026; for FY2025 (ended May 31, 2025), it was -$24,318.

  • In earlier fiscal years, EBITDA was -$11,543 in FY2024, -$41,721 in FY2023 and -$726.00 in FY2022.
  • The fiscal Q3 2026 figure marks the lowest quarterly EBITDA in data going back to fiscal Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Bryn 945.00 Bn 945.00 Bn - -
2 Veeva Systems 45.09 Bn 17.34 Bn 695.95 Mn 290.79 Mn
3 Samsara 22.22 Bn 18.99 Bn 392.58 Mn 13.29 Mn
4 Toast 17.58 Bn 10.25 Bn 516.00 Mn 188.00 Mn
5 Ptc 15.23 Bn 14.05 Bn 490.47 Mn 190.70 Mn
6 Trimble 13.37 Bn 12.44 Bn 674.90 Mn 183.10 Mn
7 Duolingo 13.34 Bn 8.51 Bn 216.74 Mn 38.19 Mn
8 Manhattan Associates 11.67 Bn 10.66 Bn 168.33 Mn 67.86 Mn
9 Costar 10.92 Bn 4.88 Bn 728.00 Mn 191.00 Mn
10 Exousia Bio 335,295.33 335,295.33 -62,108.00 -237,005.00
Historic Data

Historic Data

Download Data
DateValue
Feb 28, 2026 -237,005.00
May 31, 2025 -24,788.00
Feb 28, 2025 6,981.00
Nov 30, 2024 10,655.00
Aug 31, 2024 -668.00
May 31, 2024 -2,014.00
Feb 29, 2024 -5,021.00
Nov 30, 2023 -3,774.00
Aug 31, 2023 -8,487.00
May 31, 2023 -23,100.00
Feb 28, 2023 -4,594.00
Nov 30, 2022 -4,731.00
Aug 31, 2022 -9,296.00
API Access

Exousia Bio EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=LMMY&period=max&api_key=YOUR_API_KEY